Physician profile
Daniel M Witkin
NPI 1376997577
$1,979.22
in general payments reported to CMS, 2019-2025
31 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.23 · 2020: $14.29 · 2021: $276 · 2022: $319 · 2023: $442 · 2024: $533 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $293.76 | 2021-2025 | Grafix Pl, Collagenase Santyl, Renasys Go V2 Home |
| Advanced Oxygen Therapy INC. | $278.34 | 2022-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $228.13 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Lilly USA, LLC | $183.79 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Corcept Therapeutics | $111.16 | 2021-2023 | Korlym |
| Janssen Pharmaceuticals, INC | $102.52 | 2023-2024 | Xarelto |
| Bioventus LLC | $80.98 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Amgen INC. | $79.96 | 2021-2023 | Repatha |
| Polynovo North America LLC | $66.64 | 2022-2024 | Novosorb Btm |
| Abbvie INC. | $48.32 | 2022-2023 | Dalvance |
| Orthofix Medical, INC. | $46.71 | 2022-2024 | Physio-Stim |
| Chiesi USA, INC. | $45.88 | 2025 | Mycapssa |
| Xeris Pharmaceuticals, INC. | $35.47 | 2024 | Recorlev, Gvoke Hypopen |
| Treace Medical Concepts, INC. | $31.82 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $30.82 | 2022-2024 | Strensiq |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $27.41 | 2025 | Rezdiffra |
| Biocomposites INC | $25.51 | 2024 | |
| Aroa Biosurgery Incorporated | $22.83 | 2024 | |
| Novo Nordisk INC | $22.66 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $21.00 | 2022 | |
| Mimedx Group, INC. | $21.00 | 2025 | |
| Axogen | $20.57 | 2023 | Avance Nerve Graft |
| Medtronic, INC. | $19.44 | 2024 | Minimed 780g |
| Vifor Pharma, INC. | $19.23 | 2019 | |
| Kci USA, INC. | $18.86 | 2022 | |
| Acera Surgical, INC. | $18.80 | 2024 | Restrata Wound Matrix |
| Nevro Corp. | $18.66 | 2023 | Senza |
| Vertex Pharmaceuticals Incorporated | $15.90 | 2024 | |
| Hydrofera LLC | $15.50 | 2024 | Hydrofera Blue |
| Merck Sharp & Dohme LLC | $14.29 | 2020 | |
| Solventum Corporation | $13.26 | 2024 | V.A.C.Ulta, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Witkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.